GlassScriptPhysician profile
Ajai Sambasivan
NPI 1992090955
$1,355.66
in general payments reported to CMS, 2019-2025
10 companies · $26.90 in 2025
The $26.90 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.99 · 2020: $38.27 · 2022: $248 · 2023: $920 · 2024: $23.33 · 2025: $26.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $681 · Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $681.26 |
| Food and Beverage | $288.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $745.11 | 2023 | Sprint Pns System |
| Stryker Corporation | $174.59 | 2023 | Yukon Oct Spinal System |
| Nalu Medical, INC. | $129.33 | 2022 | |
| Grt US Holding, INC. | $96.94 | 2022 | |
| Vertiflex, INC. | $87.17 | 2019 | |
| Merz North America, INC. | $38.27 | 2020 | |
| Abbvie INC. | $26.90 | 2025 | |
| Amgen INC. | $23.33 | 2024 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $22.20 | 2022 | |
| Fidia Pharma USA INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajai Sambasivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.